These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 27632693)

  • 1. Vital Signs: Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries - United States, 2014.
    Ritchey M; Chang A; Powers C; Loustalot F; Schieb L; Ketcham M; Durthaler J; Hong Y
    MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(36):967-76. PubMed ID: 27632693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Rates of Nonadherence to Antihypertensive Medications Among Insured Adults With Hypertension, 2015.
    Chang TE; Ritchey MD; Park S; Chang A; Odom EC; Durthaler J; Jackson SL; Loustalot F
    Hypertension; 2019 Dec; 74(6):1324-1332. PubMed ID: 31679429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive adherence and outcomes among community-dwelling Medicare beneficiaries: the Atherosclerosis Risk in Communities Study.
    Federspiel JJ; Sueta CA; Kucharska-Newton AM; Beyhaghi H; Zhou L; Virani SS; Rodgers JE; Chang PP; Stearns SC
    J Eval Clin Pract; 2018 Feb; 24(1):48-55. PubMed ID: 27807921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive and Statin Medication Adherence Among Medicare Beneficiaries.
    Jackson SL; Nair PR; Chang A; Schieb L; Loustalot F; Wall HK; Sperling LS; Ritchey MD
    Am J Prev Med; 2022 Sep; 63(3):313-323. PubMed ID: 35987557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethnic disparities in adherence to antihypertensive medications of medicare part D beneficiaries.
    Holmes HM; Luo R; Hanlon JT; Elting LS; Suarez-Almazor M; Goodwin JS
    J Am Geriatr Soc; 2012 Jul; 60(7):1298-303. PubMed ID: 22702464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Antihypertensive Medication Discontinuation and Low Adherence Among Medicare Beneficiaries Initiating Treatment From 2007 to 2012.
    Tajeu GS; Kent ST; Kronish IM; Huang L; Krousel-Wood M; Bress AP; Shimbo D; Muntner P
    Hypertension; 2016 Sep; 68(3):565-75. PubMed ID: 27432867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographic variation in medication adherence in commercial and Medicare part D populations.
    Couto JE; Panchal JM; Lal LS; Bunz TJ; Maesner JE; O'Brien T; Khan T
    J Manag Care Spec Pharm; 2014 Aug; 20(8):834-42. PubMed ID: 25062077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Much Does Medication Nonadherence Cost the Medicare Fee-for-Service Program?
    Lloyd JT; Maresh S; Powers CA; Shrank WH; Alley DE
    Med Care; 2019 Mar; 57(3):218-224. PubMed ID: 30676355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonadherence to angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers among high-risk patients with diabetes in Medicare Part D programs.
    Yang Y; Thumula V; Pace PF; Banahan BF; Wilkin NE; Lobb WB
    J Am Pharm Assoc (2003); 2010; 50(4):527-31. PubMed ID: 20621872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with medication nonadherence among Medicare low-income subsidy beneficiaries with diabetes, hypertension, and/or heart failure.
    Steve Tsang CC; Browning J; Todor L; Dougherty S; Hohmeier KC; Sam Li M; Borja-Hart N; Hines LE; Wang J
    J Manag Care Spec Pharm; 2021 Aug; 27(8):971-981. PubMed ID: 34337985
    [No Abstract]   [Full Text] [Related]  

  • 11. Medication Nonadherence Among Medicare Beneficiaries with Comorbid Chronic Conditions: Influence of Pharmacy Dispensing Channel.
    Iyengar RN; LeFrancois AL; Henderson RR; Rabbitt RM
    J Manag Care Spec Pharm; 2016 May; 22(5):550-60. PubMed ID: 27123916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study.
    Yang Y; Thumula V; Pace PF; Banahan BF; Wilkin NE; Lobb WB
    Clin Ther; 2009 Oct; 31(10):2178-88; discussion 2150-1. PubMed ID: 19922889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
    Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
    Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Race/Ethnicity, disability, and medication adherence among medicare beneficiaries with heart failure.
    Zhang Y; Baik SH
    J Gen Intern Med; 2014 Apr; 29(4):602-7. PubMed ID: 24366395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
    Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
    J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members.
    Jing S; Naliboff A; Kaufman MB; Choy M
    J Manag Care Pharm; 2011 Jun; 17(5):355-66. PubMed ID: 21657805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
    McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
    JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Medicare Part D on Ethnoracial Disparities in Antidementia Medication Use.
    Lind KE; Hildreth K; Lindrooth R; Morrato E; Crane LA; Perraillon MC
    J Am Geriatr Soc; 2018 Sep; 66(9):1760-1767. PubMed ID: 30095169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive Adherence Trajectories Among Older Adults in the First Year After Initiation of Therapy.
    Hargrove JL; Pate V; Casteel CH; Golightly YM; Loehr LR; Marshall SW; Stürmer T
    Am J Hypertens; 2017 Oct; 30(10):1015-1023. PubMed ID: 28535297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Related Medication Nonadherence and Cost-Saving Behaviors Among Patients With Glaucoma Before and After the Implementation of Medicare Part D.
    Blumberg DM; Prager AJ; Liebmann JM; Cioffi GA; De Moraes CG
    JAMA Ophthalmol; 2015 Sep; 133(9):985-96. PubMed ID: 26042393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.